Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01219283 · ClinicalTrials.gov registry record
Study of the Efficacy of 24 Chromosome Preimplantation Genetic Diagnosis (PGD)
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 334
- Enrollment target
NCT01219283: Completed study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT01219283 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 334 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01219283 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 334 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if 24 chromosome preimplantation genetic diagnosis (PGD) increases implantation and delivery rates in couples attempting to conceive through in vitro fertilization (IVF).
Primary Outcome
Implantation rate per embryo transferred
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-06 |
What the finished NCT01219283 record still lists
NCT01219283 is an observational study that tracks outcomes without assigning an intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01219283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01219283 about?
NCT01219283 is a clinical study titled "Study of the Efficacy of 24 Chromosome Preimplantation Genetic Diagnosis (PGD)". The purpose of this study is to determine if 24 chromosome preimplantation genetic diagnosis (PGD) increases implantation and delivery rates in couples attempting to conceive through in vitro fertilization (IVF).
What is the current status of trial NCT01219283?
This trial is currently completed. The enrollment target is 334 participants. The study started on 2009-08. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01219283?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
- NCT05722197 · 334 participants · NA
Assessment of Emotion Regulation Strategies Used When Suicidal
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia